The point of care diagnostics market is gaining momentum as healthcare providers increasingly seek faster, accessible, and efficient diagnostic solutions. According to Grand View Research, the market was valued at USD 21.7 billion in 2025 and is projected to grow from USD 22.6 billion in 2026 to USD 29.9 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. The ability of point of care (POC) tests to provide immediate results, together with the increasing geriatric population, is expected to support continued market expansion.

The growing adoption of mobile diagnostic devices, particularly in middle-income countries, is another factor supporting market development. Government and private institutional funding is also contributing to the expansion of POC testing. At the same time, companies are introducing new diagnostic products with enhanced precision, usability, and functionality to address changing healthcare requirements.

Download a free sample copy of the Point Of Care Diagnostics market report to understand detailed coverage and inclusions in the final report

Infectious Disease Testing Holds a Strong Market Position

Infectious diseases represented the leading product segment, accounting for a 30.5% revenue share in 2025. The segment is benefiting from demand for rapid diagnostic tests and the expansion of point of care solutions into decentralized healthcare settings. Companies are also developing faster molecular testing technologies to support infectious disease detection outside conventional laboratory environments.

The cancer segment is expected to register the fastest CAGR during the forecast period. Increasing use of markers for cancer diagnostics and the rising prevalence of cancer are creating demand for earlier disease detection. Product development and regulatory approvals for companion diagnostics are also contributing to opportunities within this segment.

Clinics Continue to Drive Point Of Care Testing Adoption

Clinics held the highest revenue share among end-use segments in 2025. POC diagnostics are being adopted across primary care settings for applications ranging from glucose testing to more complex coagulation testing. Faster access to test results can shorten the time required to determine whether additional diagnostic procedures are necessary, reducing delays associated with conventional specimen preparation and transportation.

The home segment is projected to experience the highest growth rate during the forecast period. Patient comfort, cost-effectiveness, and the ability to make healthcare decisions immediately are supporting the use of POC diagnostics in home healthcare. The expanding aging population and its associated healthcare requirements are expected to further strengthen this opportunity.

Technology Is Reshaping Diagnostic Delivery

Technological advancement remains an important element of point of care diagnostics market development. Miniaturized equipment, portable testing platforms, improved automation, and healthcare information systems are making diagnostic testing more accessible across different healthcare environments. Electronic Medical Records and other information technology systems are also supporting greater market penetration.

Innovation is evident across several diagnostic categories. Portable RT-PCR equipment, advanced HbA1c testing systems, molecular diagnostics, hematology analyzers, and rapid infectious disease testing platforms are expanding the capabilities of decentralized diagnostics. Hematology POC devices can provide quality results with short turnaround times, supporting treatment decisions in emergency and other clinical settings.

Regulatory Developments and Strategic Activity Shape Competition

Regulatory frameworks play an important role in determining product approvals, market entry, and industry development. Agencies such as the U.S. FDA, European Medicines Agency, and China's NMPA influence safety, accuracy, and reliability requirements. Although regulatory complexity can increase compliance costs and delay product launches, accelerated approval pathways and initiatives such as CLIA waivers are supporting decentralized testing in settings such as pharmacies and homes.

The industry also experiences a high level of mergers and acquisitions as companies seek to expand product portfolios, enter new segments, and incorporate technologies such as molecular diagnostics and digital health solutions. The report cites Werfen's acquisition of Immucor, Inc., valued at USD 2 billion, and a Siemens Healthcare GmbH partnership with Unilabs involving an agreed value exceeding USD 200 million.

Regional Expansion Creates New Growth Opportunities

North America dominated the point of care diagnostics market with a 37.1% share in 2025. Its leading position is supported by the growing geriatric population, higher healthcare expenditure, technological advancements, and the presence of major diagnostic companies.

Asia Pacific is identified as the fastest-growing regional market, with a CAGR of 6.29% over the forecast period. Healthcare infrastructure development, increasing prevalence of chronic and infectious diseases, adoption of miniaturized diagnostic systems, and expanding POC applications are supporting growth. The report also highlights rising demand for POC diagnostics in operating rooms, emergency rooms, intensive care units, pathology laboratories, and hospitals.

FAQs

What is driving point of care diagnostics market growth?

Growth is being supported by the increasing geriatric population, demand for immediate diagnostic results, adoption of mobile and portable diagnostic devices, rising disease prevalence, technological improvements, healthcare information systems, government and private funding, and greater patient awareness.

Which segment leads the point of care diagnostics market?

Infectious diseases led the product segment with a 30.5% revenue share in 2025, while clinics held the highest revenue share among end-use segments in the same year.

Key Point Of Care Diagnostics Companies:

·        F. Hoffmann-La Roche Ltd.

·        Qiagen

·        Danaher Corporation

·        Becton Dickinson (BD)

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.